6,7-Dimethyl-2-phenylquinoxaline

CC1=C(C)C=C2N=C(C=NC2=C1)C3=CC=CC=C3

InChIKey=FQNCLVJEQCJWSU-UHFFFAOYSA-N

InChI=1S/C16H14N2/c1-11-8-14-15(9-12(11)2)18-16(10-17-14)13-6-4-3-5-7-13/h3-10H,1-2H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Targets

Primary Target	Pharmacology	Condition	Potency
Platelet-derived growth factor receptor 6 Target ID: CHEMBL2095189 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7954456 \| https://www.ncbi.nlm.nih.gov/pubmed/18600399	Inhibitor 8504

PubMed

Title	Date	PubMed
Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.	2008	18600399
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.	1994-12-01	7954456

Substance Class	Chemical Created by `admin` on `Wed Apr 02 05:17:14 GMT 2025` Edited by `admin` on `Wed Apr 02 05:17:14 GMT 2025`
Record UNII	FWH2FYS649
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

6,7-Dimethyl-2-phenylquinoxaline

Systematic Name

English

AG-1295

Preferred Name

English

6,7-DIMETHYL-2-PHENYL-QUINOXALINE

Systematic Name

English

Quinoxaline, 6,7-dimethyl-2-phenyl-

Systematic Name

English

Tyrphostin AG1295

Common Name

English

2-Phenyl-6,7-dimethylquinoxaline

Systematic Name

English

NSC-380341

Code

English

Code System Code Type Description

FDA UNII

FWH2FYS649